Boston Scientific Forecasts Net Sales Growth For 2024 Of 11%-13% On Reported Basis And 10%-12% On Organic Basis Compared To Prior Guidance Of Approximately 8.5%-9.5% And 8%-9%, Respectively
Portfolio Pulse from Benzinga Newsdesk
Boston Scientific has updated its net sales growth forecast for 2024, projecting an increase of 11%-13% on a reported basis and 10%-12% on an organic basis. This is a significant improvement from the previously guided ranges of approximately 8.5%-9.5% and 8%-9%, respectively.
April 24, 2024 | 10:36 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Boston Scientific raises its 2024 sales growth forecast significantly, indicating stronger performance ahead.
The substantial upward revision in Boston Scientific's sales growth forecast for 2024 suggests a positive outlook for the company's financial health and operational efficiency. This revision is likely to be viewed favorably by investors, potentially leading to increased investor confidence and a positive impact on the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100